loading

Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie

pulisher
Aug 20, 2025

VistaGen Therapeutics (NASDAQ:VTGN) Rating Increased to Hold at Wall Street Zen - MarketBeat

Aug 20, 2025
pulisher
Aug 20, 2025

Can Vistagen Therapeutics Inc. Bounce Back From Weekly Low2025 Geopolitical Influence & Long Hold Capital Preservation Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is now a turning point for Vistagen Therapeutics Inc.Weekly Earnings Recap & AI Enhanced Trading Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Analyzing recovery setups for Vistagen Therapeutics Inc. investorsEarnings Trend Report & Weekly High Return Forecasts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What to do if you’re stuck in Vistagen Therapeutics Inc.Portfolio Value Report & Stock Portfolio Risk Control - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Vistagen Therapeutics Inc.’s volatility index tracking explained2025 Trade Ideas & Accurate Buy Signal Notifications - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Earnings visualization tools for Vistagen Therapeutics Inc.Market Volume Report & Accurate Intraday Trade Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Volatility clustering patterns for Vistagen Therapeutics Inc.2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to build a custom watchlist for Vistagen Therapeutics Inc.Weekly Gains Summary & Verified Entry Point Signals - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Using AI based signals to follow Vistagen Therapeutics Inc.Market Sentiment Report & Weekly Top Performers Watchlists - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Can trapped investors hope for a rebound in Vistagen Therapeutics Inc.Bull Run & Technical Entry and Exit Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How to interpret RSI for Vistagen Therapeutics Inc. stockShare Buyback & Stock Portfolio Risk Management - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using Python tools to backtest Vistagen Therapeutics Inc. strategiesWeekly Profit Summary & Verified Entry Point Signals - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

What candlestick patterns are forming on Vistagen Therapeutics Inc.GDP Growth & Safe Entry Trade Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Heatmap analysis for Vistagen Therapeutics Inc. and competitorsTrade Exit Report & Comprehensive Market Scan Insights - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Vistagen Therapeutics Inc. stock outlook for YEAREarnings Growth Report & Community Verified Swing Trade Signals - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Intraday pattern recognizer results for Vistagen Therapeutics Inc.Weekly Loss Report & High Return Stock Watch Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Will Vistagen Therapeutics Inc. see short term momentum2025 Analyst Calls & Trade Opportunity Analysis Reports - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Why Vistagen Therapeutics Inc. stock attracts strong analyst attentionExit Point & Expert Approved Momentum Ideas - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

How to track smart money flows in Vistagen Therapeutics Inc.Portfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Vistagen Therapeutics Inc. trending in predictive chart modelsWeekly Profit Recap & Weekly Breakout Watchlists - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Retail Investors Hold Significant Control Over Vistagen Therapeutics, Inc. - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

retail investors who own 49% along with institutions invested in Vistagen Therapeutics, Inc. (NASDAQ:VTGN) saw increase in their holdings value last week - simplywall.st

Aug 17, 2025
pulisher
Aug 17, 2025

Technical analysis overview for Vistagen Therapeutics Inc. stockJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Using R and stats models for Vistagen Therapeutics Inc. forecastingAnalyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Evaluating Vistagen Therapeutics Inc. with trendline analysisWeekly Trade Review & Fast Moving Stock Trade Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Is Vistagen Therapeutics Inc. stock a good hedge against inflationJuly 2025 Highlights & Real-Time Market Sentiment Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Vistagen Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

Aug 16, 2025
pulisher
Aug 15, 2025

What makes Vistagen Therapeutics Inc. stock attractive to long term investorsRate Cut & Verified Momentum Watchlists - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q1 2026 Earnings Call Transcript - MSN

Aug 14, 2025
pulisher
Aug 14, 2025

Vistagen Therapeutics Inc. Q1 Earnings Call Highlights: Progress Amid Challenges and Financial Pressures. - AInvest

Aug 14, 2025
pulisher
Aug 13, 2025

VistaGen Therapeutics (NASDAQ:VTGN) Posts Quarterly Earnings Results - MarketBeat

Aug 13, 2025
pulisher
Aug 13, 2025

Vistagen (VTGN) Q1 R&D Expense Jumps 54% - AOL.com

Aug 13, 2025
pulisher
Aug 12, 2025

Published on: 2025-08-12 05:18:03 - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Is Vistagen Therapeutics Inc. stock a good dividend stockGame-Changing Investment Alerts - thegnnews.com

Aug 12, 2025
pulisher
Aug 12, 2025

VistaGen Therapeutics, Inc. (VTGN) Reports Q1 Loss, Misses Revenue Estimates - MSN

Aug 12, 2025
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Capitalizzazione:     |  Volume (24 ore):